Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis

NCT05999955 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinosinusitis
Rhinitis

Interventions

DRUG: Neomycin/ Dexameythasone/Xylometazoline
COMBINATION_PRODUCT: Bacillus subtilis DSM32444

Sponsor

Huro Biotech Joint Stock Company

Collaborators

[object Object]